Ironwood Financial’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Ironwood Financial’s Portfolio HTGM Stock Details HTGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9	Closed	-$1K	–	592
2021 Q3	$1K	Hold	9	–	–	﹤0.01%	557
2021 Q2	$1K	Hold	9	–	–	﹤0.01%	545
2021 Q1	$1K	Hold	9	–	–	﹤0.01%	528
2020 Q4	$0	Hold	9	–	–	﹤0.01%	507
2020 Q3	$1K	Hold	9	–	–	﹤0.01%	426
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	397
2020 Q1	$1K	Hold	9	–	–	﹤0.01%	341
2019 Q4	$1K	Hold	9	–	–	﹤0.01%	370
2019 Q3	$1K	Hold	9	–	–	﹤0.01%	375
2019 Q2	$3K	Hold	9	–	–	﹤0.01%	341
2019 Q1	$4K	Hold	9	–	–	﹤0.01%	324
2018 Q4	$4K	Hold	9	–	–	﹤0.01%	318
2018 Q3	$8K	Sell	9 -7	-44%	-$4.62K	﹤0.01%	275
2018 Q2	$9K	Buy	16 +8	+100%	+$5.22K	0.01%	198
2018 Q1	$5K	Hold	8	–	–	0.01%	211
2017 Q4	$3K	Hold	8	–	–	﹤0.01%	227
2017 Q3	$3K	Hold	8	–	–	﹤0.01%	236
2017 Q2	$4K	Hold	8	–	–	﹤0.01%	224
2017 Q1	$10K	Sell	8 -7	-47%	-$3.37K	0.01%	173
2016 Q4	$6K	Buy	15 +10	+200%	+$3.99K	﹤0.01%	201
2016 Q3	$2K	Hold	5	–	–	﹤0.01%	251
2016 Q2	$2K	Hold	5	–	–	﹤0.01%	255
2016 Q1	$2K	Buy	+5	New	+$2.79K	﹤0.01%	259
2015 Q3	$7K	Buy	5 +3	+150%	+$4.63K	﹤0.01%	238
2015 Q2	$3K	Buy	+2	New	+$5.11K	﹤0.01%	285

Other funds holding HTGM

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ironwood Financial's HTGM Position: Q4 2021 in Review

Ironwood Financial sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q4 2021, closing a stake of 9 shares — an estimated $1K sold.

Ironwood Financial first reported a position in HTGM in Q2 2015 and held it in 25 quarters. The position peaked at $10K in Q1 2017. 21 funds tracked by Wall St. Rank hold HTGM as of Q4 2021.

Ironwood Financial reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 9 HTG Molecular Diagnostics, Inc. Common Stock shares in Q4 2021, an estimated $1K.
Ironwood Financial first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2015 and held it in 25 quarters.
Ironwood Financial's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $10K in Q1 2017.
21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.